Literature DB >> 27354023

Donor and recipient sex in allogeneic stem cell transplantation: what really matters.

Haesook T Kim1, Mei-Jie Zhang2, Ann E Woolfrey3, Andrew St Martin4, Junfang Chen4, Wael Saber4, Miguel-Angel Perales5, Philippe Armand6, Mary Eapen4.   

Abstract

We investigated whether and how recipient-donor sex affects transplantation outcomes of 11,797 patients transplanted between 2008 and 2010. Thirty-seven percent were male recipients with male donors, 21% male recipients with female donors, 25% female recipients with male donors, and 17% female recipients with female donors. In multivariable analyses, male recipients had inferior overall survival and progression-free survival compared to females regardless of donor sex, with an 11% relative increase in the hazard of death (P<0.0001) and a 10% relative increase in the hazard of death or relapse (P<0.0001). The detrimental effect of male recipients varied by donor sex. For male recipients with male donors, there was a 12% relative increase in the subdistribution hazard of relapse compared with female recipients with male donors (P=0.0036) and male recipients with female donors (P=0.0037). For male recipients with female donors, there was a 19% relative increase in the subdistribution hazard of non-relapse mortality compared with male recipients with male donors (P<0.0001) and a 22% relative increase compared with female recipients with male donors (P=0.0003). In addition, male recipients with female donors showed a 21% relative increase in the subdistribution hazard of chronic graft-versus-host disease (P<0.0001) compared with female recipients with male donors. Donor sex had no effect on outcomes for female recipients. Transplantation of grafts from male and female donors was associated with inferior overall survival and progression-free survival in male recipients with differing patterns of failure. Recipient sex is an important prognostic factor independent of donor sex. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Year:  2016        PMID: 27354023      PMCID: PMC5046656          DOI: 10.3324/haematol.2016.147645

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  21 in total

1.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Authors:  David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

2.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

Review 3.  The EBMT risk score.

Authors:  A Gratwohl
Journal:  Bone Marrow Transplant       Date:  2011-06-06       Impact factor: 5.483

4.  Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Authors:  Sally Arai; Mukta Arora; Tao Wang; Stephen R Spellman; Wensheng He; Daniel R Couriel; Alvaro Urbano-Ispizua; Corey S Cutler; Andrea A Bacigalupo; Minoo Battiwalla; Mary E Flowers; Mark B Juckett; Stephanie J Lee; Alison W Loren; Thomas R Klumpp; Susan E Prockup; Olle T H Ringdén; Bipin N Savani; Gérard Socié; Kirk R Schultz; Thomas Spitzer; Takanori Teshima; Christopher N Bredeson; David A Jacobsohn; Robert J Hayashi; William R Drobyski; Haydar A Frangoul; Görgün Akpek; Vincent T Ho; Victor A Lewis; Robert Peter Gale; John Koreth; Nelson J Chao; Mahmoud D Aljurf; Brenda W Cooper; Mary J Laughlin; Jack W Hsu; Peiman Hematti; Leo F Verdonck; Melhelm M Solh; Maxim Norkin; Vijay Reddy; Rodrigo Martino; Shahinaz Gadalla; Jenna D Goldberg; Philip L McCarthy; José A Pérez-Simón; Nandita Khera; Ian D Lewis; Yoshiko Atsuta; Richard F Olsson; Wael Saber; Edmund K Waller; Didier Blaise; Joseph A Pidala; Paul J Martin; Prakash Satwani; Martin Bornhäuser; Yoshihiro Inamoto; Daniel J Weisdorf; Mary M Horowitz; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-30       Impact factor: 5.742

5.  A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia.

Authors:  Theis H Terwey; Philipp G Hemmati; Peter Martus; Ekkehart Dietz; Lam G Vuong; Gero Massenkeil; Bernd Dörken; Renate Arnold
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

6.  Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  A Gratwohl; J Hermans; J M Goldman; W Arcese; E Carreras; A Devergie; F Frassoni; G Gahrton; H J Kolb; D Niederwieser; T Ruutu; J P Vernant; T de Witte; J Apperley
Journal:  Lancet       Date:  1998-10-03       Impact factor: 79.321

7.  Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.

Authors:  Sophia S B Randolph; Theodore A Gooley; Edus H Warren; Frederick R Appelbaum; Stanley R Riddell
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

8.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

Review 9.  Risk assessment in haematopoietic stem cell transplantation: impact of donor-recipient sex combination in allogeneic transplantation.

Authors:  Gösta Gahrton
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020

10.  The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.

Authors:  Craig Kollman; Stephen R Spellman; Mei-Jie Zhang; Anna Hassebroek; Claudio Anasetti; Joseph H Antin; Richard E Champlin; Dennis L Confer; John F DiPersio; Marcelo Fernandez-Viña; Robert J Hartzman; Mary M Horowitz; Carolyn K Hurley; Chatchada Karanes; Martin Maiers; Carlheinz R Mueller; Miguel-Angel Perales; Michelle Setterholm; Ann E Woolfrey; Neng Yu; Mary Eapen
Journal:  Blood       Date:  2015-11-02       Impact factor: 22.113

View more
  20 in total

1.  Group and within-group variable selection for competing risks data.

Authors:  Kwang Woo Ahn; Anjishnu Banerjee; Natasha Sahr; Soyoung Kim
Journal:  Lifetime Data Anal       Date:  2017-08-04       Impact factor: 1.588

2.  Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.

Authors:  Anita J Kumar; Soyoung Kim; Michael T Hemmer; Mukta Arora; Stephen R Spellman; Joseph A Pidala; Daniel R Couriel; Amin M Alousi; Mahmoud D Aljurf; Jean-Yves Cahn; Mitchell S Cairo; Corey S Cutler; Shatha Farhan; Usama Gergis; Gregory A Hale; Shahrukh K Hashmi; Yoshihiro Inamoto; Rammurti T Kamble; Mohamed A Kharfan-Dabaja; Margaret L MacMillan; David I Marks; Hideki Nakasone; Maxim Norkin; Muna Qayed; Olle Ringden; Harry C Schouten; Kirk R Schultz; Melhem M Solh; Takanori Teshima; Alvaro Urbano-Ispizua; Leo F Verdonck; Robert Peter Gale; Betty K Hamilton; Navneet S Majhail; Alison W Loren
Journal:  Blood Adv       Date:  2018-05-08

3.  Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation.

Authors:  Yasuyuki Arai; Tadakazu Kondo; Kyoko Fuse; Yasuhiko Shibasaki; Masayoshi Masuko; Junichi Sugita; Takanori Teshima; Naoyuki Uchida; Takahiro Fukuda; Kazuhiko Kakihana; Yukiyasu Ozawa; Tetsuya Eto; Masatsugu Tanaka; Kazuhiro Ikegame; Takehiko Mori; Koji Iwato; Tatsuo Ichinohe; Yoshinobu Kanda; Yoshiko Atsuta
Journal:  Blood Adv       Date:  2019-11-26

4.  Droplet Digital PCR-Based Chimerism Analysis for Primary Immunodeficiency Diseases.

Authors:  Tsubasa Okano; Yuki Tsujita; Hirokazu Kanegane; Kanako Mitsui-Sekinaka; Kay Tanita; Satoshi Miyamoto; Tzu-Wen Yeh; Motoi Yamashita; Naomi Terada; Yumi Ogura; Masatoshi Takagi; Kohsuke Imai; Shigeaki Nonoyama; Tomohiro Morio
Journal:  J Clin Immunol       Date:  2018-04-18       Impact factor: 8.317

5.  Donor Characteristics Predict the Success of Allogeneic Hematopoietic Stem Cell Transplantation in Thalassemia Major: A Single-Center Analysis of 250 Patients.

Authors:  Revathi Raj; Venkateswaran Vellaichamy Swaminathan; Satishkumar Meena; Harika Varla; Rumesh Chandar; Balasubramaniam Ramakrishnan; Mythyly Vaikuntham; Venkadadesikalu Maljetty; Ramya Uppuluri
Journal:  Indian J Hematol Blood Transfus       Date:  2021-09-07       Impact factor: 0.900

Review 6.  Sex-Specific Cardiovascular Risks of Cancer and Its Therapies.

Authors:  Nicholas S Wilcox; Seth J Rotz; McKay Mullen; Evelyn J Song; Betty Ky Hamilton; Javid Moslehi; Saro H Armenian; Joseph C Wu; June-Wha Rhee; Bonnie Ky
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

7.  Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.

Authors:  Wael Saber; Jennifer R Brown; Haesook T Kim; Kwang Woo Ahn; Zhen-Huan Hu; Matthew S Davids; Virginia O Volpe; Joseph H Antin; Mohamed L Sorror; Mazyar Shadman; Oliver Press; Joseph Pidala; William Hogan; Robert Negrin; Steven Devine; Joseph Uberti; Edward Agura; Richard Nash; Jayesh Mehta; Joseph McGuirk; Stephen Forman; Amelia Langston; Sergio A Giralt; Miguel-Angel Perales; Minoo Battiwalla; Gregory A Hale; Robert Peter Gale; David I Marks; Mehdi Hamadani; Sid Ganguly; Ulrike Bacher; Hillard Lazarus; Ran Reshef; Gerhard C Hildebrandt; Yoshihiro Inamoto; Jean-Yves Cahn; Melhem Solh; Mohamed A Kharfan-Dabaja; Nilanjan Ghosh; Ayman Saad; Mahmoud Aljurf; Harry C Schouten; Brian T Hill; Attaphol Pawarode; Tamila Kindwall-Keller; Nakhle Saba; Edward A Copelan; Sunita Nathan; Amer Beitinjaneh; Bipin N Savani; Jan Cerny; Michael R Grunwald; Jean Yared; Baldeep M Wirk; Taiga Nishihori; Saurabh Chhabra; Richard F Olsson; Asad Bashey; Usama Gergis; Uday Popat; Ronald Sobecks; Edwin Alyea
Journal:  Clin Cancer Res       Date:  2019-06-28       Impact factor: 12.531

8.  Early and Late Complications in Patients with Allogeneic Transplantation of Hematopoietic Stem Cell - Case Report.

Authors:  Ivana Trajkovska; Borce Georgievski; Lidija Cevreska; Andrijana Gacovski; Taner Hasan; Natasha Nedeska-Minova
Journal:  Open Access Maced J Med Sci       Date:  2017-05-09

9.  Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study.

Authors:  Lan-Ping Xu; Shun-Qing Wang; Yan-Ru Ma; Su-Jun Gao; Yi-Fei Cheng; Yuan-Yuan Zhang; Wen-Jian Mo; Xiao-Dong Mo; Yu-Ping Zhang; Chen-Hua Yan; Yu-Hong Chen; Ming Zhou; Yu Wang; Xiao-Hui Zhang; Kai-Yan Liu; Xiao-Jun Huang
Journal:  J Hematol Oncol       Date:  2019-09-02       Impact factor: 17.388

10.  Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Prioty Islam; Helen Tang; Haesu Jin; Felicia Cao; Lauren M Bohannon; Yi Ren; Nelson J Chao; Taewoong Choi; Cristina Gasparetto; Mitchell E Horwitz; Gwynn D Long; Richard D Lopez; David A Rizzieri; Stefanie Sarantopoulos; Anthony D Sung
Journal:  Transplant Cell Ther       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.